J Korean Med Sci.  2022 Nov;37(44):e331. 10.3346/jkms.2022.37.e331.

The Baseline Seroprevalence of SARS-CoV-2 Before the Omicron Surge in Korean Children – The Calm Before the Perfect Storm

• Jo DS

• KMID: 2535183
• DOI: http://doi.org/10.3346/jkms.2022.37.e331

Reference

1. Kang HM, Park JY, Choe YJ. Clinical manifestations, epidemiologic characteristics, and disease burden of the Coronavirus Disease-19 in children ages 5-11 years old. Pediatr Infect Vaccine. 2022; 29(2):61–69.

2. Lee J, Choe YJ, Minn D, Kim JH. The seroprevalence of SARS-CoV-2 in children during early COVID-19 pandemic in Korea: a nationwide, population-based study. J Korean Med Sci. 2022; 37(44):e314. PMID: 36377292.

3. Cho EY, Kim DH, Choi SH, Yun KW, Ahn JG, Cho HK, et al. Statement on healthcare system preparedness in response to COVID-19 omicron subvariants BA.4 and BA.5 surge in Korea from the Korean Pediatric Society and Korean Society of Pediatric Infectious Diseases. Clin Exp Pediatr. 2022; 65(11):510–511. PMID: 36229026.

4. Ministry of Health and Welfare. Press Release. 2022. Updated September 26, 2022. Accessed November 6, 2022. https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&act=view&list_no=720760 .

5. Korea Disease Control and Prevention Agency. Infectious diseases surveillance yearbook 2020. Accessed November 6, 2022. https://www.kdca.go.kr/npt/biz/npp/portal/nppPblctDtaView.do?pblctDtaSeAt=1&pblctDtaSn=2452 .

6. Korea Disease Control and Prevention Agency. Infectious diseases surveillance yearbook 2021. Accessed November 6, 2022. https://www.kdca.go.kr/npt/biz/npp/portal/nppPblctDtaView.do?pblctDtaSeAt=1&pblctDtaSn=2682 .